Company: SION
Filing Date: 2025-02-10
Form Type: 8-K
Source: 0001193125-25-023570
Chunk: 1

Company: Sionna Therapeutics, Inc.
Filing Date: 2025-02-10
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  3.1      Fifth Amended and Restated Certificate of Incorporation of Sionna Therapeutics, Inc.  
  3.2      Amended and Restated Bylaws of Sionna Therapeutics, Inc.                              
  104      Cover Page Interactive Data File (embedded within the Inline XBRL document).          

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                                        Sionna Therapeutics, Inc.                     
  Date: February 10, 2025      By:      /s/ Michael Cloonan                           
                                        Name: Michael Cloonan, M. B. A.               
                                        Title: President and Chief Executive Officer